These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 15781862)

  • 21. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
    Lin J; Tang H; Jin X; Jia G; Hsieh JT
    Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.
    Lin L; Hutzen B; Zuo M; Ball S; Deangelis S; Foust E; Pandit B; Ihnat MA; Shenoy SS; Kulp S; Li PK; Li C; Fuchs J; Lin J
    Cancer Res; 2010 Mar; 70(6):2445-54. PubMed ID: 20215512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stat3 upregulates MEK5 expression in human breast cancer cells.
    Song H; Jin X; Lin J
    Oncogene; 2004 Oct; 23(50):8301-9. PubMed ID: 15378007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells.
    Nagel-Wolfrum K; Buerger C; Wittig I; Butz K; Hoppe-Seyler F; Groner B
    Mol Cancer Res; 2004 Mar; 2(3):170-82. PubMed ID: 15037656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system.
    Sriuranpong V; Park JI; Amornphimoltham P; Patel V; Nelkin BD; Gutkind JS
    Cancer Res; 2003 Jun; 63(11):2948-56. PubMed ID: 12782602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.
    Niu G; Wright KL; Huang M; Song L; Haura E; Turkson J; Zhang S; Wang T; Sinibaldi D; Coppola D; Heller R; Ellis LM; Karras J; Bromberg J; Pardoll D; Jove R; Yu H
    Oncogene; 2002 Mar; 21(13):2000-8. PubMed ID: 11960372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein.
    Turkson J; Bowman T; Adnane J; Zhang Y; Djeu JY; Sekharam M; Frank DA; Holzman LB; Wu J; Sebti S; Jove R
    Mol Cell Biol; 1999 Nov; 19(11):7519-28. PubMed ID: 10523640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells.
    Shin DS; Kim HN; Shin KD; Yoon YJ; Kim SJ; Han DC; Kwon BM
    Cancer Res; 2009 Jan; 69(1):193-202. PubMed ID: 19118003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
    Toyonaga T; Nakano K; Nagano M; Zhao G; Yamaguchi K; Kuroki S; Eguchi T; Chijiiwa K; Tsuneyoshi M; Tanaka M
    Cancer Lett; 2003 Nov; 201(1):107-16. PubMed ID: 14580692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization.
    Schust J; Sperl B; Hollis A; Mayer TU; Berg T
    Chem Biol; 2006 Nov; 13(11):1235-42. PubMed ID: 17114005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STATs in oncogenesis.
    Bowman T; Garcia R; Turkson J; Jove R
    Oncogene; 2000 May; 19(21):2474-88. PubMed ID: 10851046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cells.
    Yu CY; Wang L; Khaletskiy A; Farrar WL; Larner A; Colburn NH; Li JJ
    Oncogene; 2002 Jun; 21(25):3949-60. PubMed ID: 12037677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
    Song L; Turkson J; Karras JG; Jove R; Haura EB
    Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways.
    Xu Q; Briggs J; Park S; Niu G; Kortylewski M; Zhang S; Gritsko T; Turkson J; Kay H; Semenza GL; Cheng JQ; Jove R; Yu H
    Oncogene; 2005 Aug; 24(36):5552-60. PubMed ID: 16007214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stat3 modulates heat shock 27kDa protein expression in breast epithelial cells.
    Song H; Ethier SP; Dziubinski ML; Lin J
    Biochem Biophys Res Commun; 2004 Jan; 314(1):143-50. PubMed ID: 14715258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational analysis of acute-phase response factor/Stat3 activation and dimerization.
    Sasse J; Hemmann U; Schwartz C; Schniertshauer U; Heesel B; Landgraf C; Schneider-Mergener J; Heinrich PC; Horn F
    Mol Cell Biol; 1997 Aug; 17(8):4677-86. PubMed ID: 9234724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression.
    Epling-Burnette PK; Liu JH; Catlett-Falcone R; Turkson J; Oshiro M; Kothapalli R; Li Y; Wang JM; Yang-Yen HF; Karras J; Jove R; Loughran TP
    J Clin Invest; 2001 Feb; 107(3):351-62. PubMed ID: 11160159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGFR dependent expression of STAT3 (but not STAT1) in breast cancer.
    Berclaz G; Altermatt HJ; Rohrbach V; Siragusa A; Dreher E; Smith PD
    Int J Oncol; 2001 Dec; 19(6):1155-60. PubMed ID: 11713584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
    Zhang T; Ma J; Cao X
    Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes.
    Zhang X; Yue P; Fletcher S; Zhao W; Gunning PT; Turkson J
    Biochem Pharmacol; 2010 May; 79(10):1398-409. PubMed ID: 20067773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.